Acrospire Investment Management’s Forward Pharma A/S American Depositary Shares FWP Stock Holding History

Acrospire Investment Management’s Portfolio FWP Stock Details FWP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-135	Closed	-$19K	–	1840
2017 Q2	$19K	Sell	135 -19	-12%	-$2.64K	0.02%	1567
2017 Q1	$23K	Sell	154 -75	-33%	-$14.1K	0.02%	1556
2016 Q4	$24K	Buy	229 +154	+205%	+$20.3K	0.01%	1707
2016 Q3	$11K	Sell	75 -57	-43%	-$8.02K	0.01%	1689
2016 Q2	$17K	Sell	132 -43	-25%	-$5.8K	0.01%	1592
2016 Q1	$21K	Buy	+175	New	+$19.6K	0.01%	1523

Other funds holding FWP

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

AIM

Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

FIM

Freedom Investment Management Hartford, Connecticut $359M AUM 23.01% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Acrospire Investment Management's FWP Position: Q3 2017 in Review

Acrospire Investment Management sold out of Forward Pharma A/S American Depositary Shares (FWP) in Q3 2017, closing a stake of 135 shares — an estimated $19K sold.

Acrospire Investment Management first reported a position in FWP in Q1 2016 and held it in 6 quarters. The position peaked at $24K in Q4 2016. 19 funds tracked by Wall St. Rank hold FWP as of Q3 2017.

Acrospire Investment Management reported no remaining Forward Pharma A/S American Depositary Shares position as of Q3 2017 after selling out during the quarter.
Acrospire Investment Management sold 135 Forward Pharma A/S American Depositary Shares shares in Q3 2017, an estimated $19K.
Acrospire Investment Management first reported a position in Forward Pharma A/S American Depositary Shares in Q1 2016 and held it in 6 quarters.
Acrospire Investment Management's Forward Pharma A/S American Depositary Shares position peaked at $24K in Q4 2016.
19 funds tracked by Wall St. Rank held Forward Pharma A/S American Depositary Shares as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.